SEC CIK 1504635
FRANKLIN SHIRLEY C.
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| MWAview stock → | 65,043 | 2025-03-05 |
| DALview stock → | 36,760 | 2016-12-19 |
Position History — MWA
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — MWA
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2025-03-05 | Open-market sale | 7,376 | $24.67 | 65,043 |
| 2025-02-24 | Open-market sale | 8,825 | $25.11 | 72,419 |
| 2025-02-06 | Grant / award | 4,672 | $0.00 | 12,048 |
| 2024-02-28 | Grant / award | 7,376 | $0.00 | 7,376 |
| 2023-02-07 | Grant / award | 8,267 | $0.00 | 8,267 |
| 2022-06-01 | Open-market sale | 7,000 | $11.94 | 56,776 |
| 2022-02-11 | Open-market sale | 5,000 | $13.04 | 63,776 |
| 2022-02-07 | Grant / award | 8,825 | $0.00 | 17,047 |
| 2021-11-01 | Option exercise (derivative) | 2,697 | $0.00 | 0 |
| 2021-11-01 | Option exercise | 2,697 | $9.97 | 63,251 |
| 2021-11-01 | Option exercise | 2,414 | $8.58 | 65,665 |
| 2021-11-01 | Open-market sale | 2,414 | $16.43 | 63,251 |
| 2021-11-01 | Open-market sale | 2,697 | $16.43 | 60,554 |
| 2021-10-01 | Option exercise (derivative) | 2,698 | $0.00 | 2,697 |
| 2021-10-01 | Option exercise (derivative) | 2,414 | $0.00 | 2,414 |
| 2021-10-01 | Open-market sale | 2,414 | $15.28 | 63,252 |
| 2021-10-01 | Open-market sale | 2,698 | $15.28 | 60,554 |
| 2021-10-01 | Option exercise | 2,414 | $8.58 | 65,666 |
| 2021-10-01 | Option exercise | 2,698 | $9.97 | 63,252 |
| 2021-09-01 | Option exercise (derivative) | 2,698 | $0.00 | 5,395 |
| 2021-09-01 | Option exercise (derivative) | 2,414 | $0.00 | 4,828 |
| 2021-09-01 | Open-market sale | 2,698 | $16.62 | 60,554 |
| 2021-09-01 | Open-market sale | 2,414 | $16.62 | 63,252 |
| 2021-09-01 | Option exercise | 2,414 | $8.58 | 65,666 |
| 2021-09-01 | Option exercise | 2,698 | $9.97 | 63,252 |
| 2021-08-02 | Option exercise (derivative) | 2,414 | $0.00 | 7,242 |
| 2021-08-02 | Option exercise (derivative) | 2,698 | $0.00 | 8,093 |
| 2021-08-02 | Option exercise | 2,414 | $8.58 | 65,666 |
| 2021-08-02 | Open-market sale | 2,414 | $15.00 | 63,252 |
| 2021-08-02 | Open-market sale | 2,698 | $15.00 | 60,554 |
| 2021-08-02 | Option exercise | 2,698 | $9.97 | 63,252 |
| 2021-03-04 | Option exercise (derivative) | 12,578 | $0.00 | 0 |
| 2021-03-04 | Option exercise | 6,965 | $2.79 | 80,097 |
| 2021-03-04 | Open-market sale | 6,965 | $12.80 | 73,132 |
| 2021-03-04 | Open-market sale | 12,578 | $12.80 | 60,554 |
| 2021-03-04 | Option exercise | 12,578 | $5.91 | 73,132 |
| 2021-02-09 | Grant / award | 8,222 | $0.00 | 8,222 |
| 2020-09-02 | Option exercise (derivative) | 25,806 | $0.00 | 0 |
| 2020-09-02 | Open-market sale | 25,806 | $11.11 | 51,913 |
| 2020-09-02 | Option exercise | 25,806 | $2.92 | 77,719 |
| 2020-01-29 | Grant / award | 8,641 | $0.00 | 8,641 |
| 2019-11-25 | Open-market sale | 12,808 | $11.12 | 40,084 |
| 2019-06-12 | Open-market sale | 6,700 | $9.55 | 52,892 |
| 2019-01-23 | Grant / award | 9,625 | $0.00 | 25,108 |
| 2018-01-24 | Grant / award | 7,627 | $0.00 | 22,639 |
| 2017-06-14 | Open-market sale | 9,156 | $11.40 | 39,157 |
| 2017-01-25 | Grant / award | 6,612 | $0.00 | 21,712 |
| 2016-02-26 | Grant / award | 10,344 | $8.70 | 15,100 |
| 2015-01-28 | Grant / award (derivative) | 10,791 | $0.00 | 10,791 |
| 2015-01-28 | Grant / award | 4,513 | $9.97 | 14,269 |
| 2014-01-29 | Grant / award (derivative) | 9,656 | $0.00 | 9,656 |
| 2014-01-29 | Grant / award | 5,244 | $0.00 | 17,164 |
| 2013-01-30 | Grant / award (derivative) | 12,578 | $0.00 | 12,578 |
| 2013-01-30 | Grant / award | 6,768 | $0.00 | 21,868 |
| 2012-01-25 | Grant / award (derivative) | 6,965 | $0.00 | 6,965 |
| 2012-01-25 | Grant / award | 15,456 | $0.00 | 29,844 |
| 2010-11-01 | Grant / award (derivative) | 25,806 | $1.55 | 25,806 |
| 2010-11-01 | Grant / award | 14,388 | $0.00 | 14,388 |
| 2010-11-01 | Grant / award (derivative) | 25,806 | $2.92 | 25,806 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.